文献速递妇产影像介入US

大型胎盘绒毛膜血管瘤的管理:双孔激光胎儿介入治疗

Management of large placental chorioangioma: two-port laser approach for fetal intervention.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

该回顾性队列研究纳入2011年1月至2022年12月单中心34例大型胎盘绒毛膜血管瘤(直径≥4 cm)患者,比较期待管理与宫内干预的结局,并描述不同宫内阻断肿瘤血供技术的相关结局;期待管理组活产率显著高于干预组(96.0% vs 62.5%,P=0.01),干预时已出现水肿的3例均胎死宫内,作者提出宫内干预应在胎儿水肿发生前启动。

要点

  • 大型胎盘绒毛膜血管瘤(直径≥4 cm)干预组羊水过多发生率显著高于期待管理组(66.7% vs 8.0%,P<0.001)。
  • 期待管理组活产率显著高于宫内干预组(96.0% vs 62.5%,P=0.01)。
  • 干预时已存在水肿的3例均胎死宫内,作者提出宫内干预应在胎儿水肿发生前启动。

核心结论

  • 阻断供血血管的宫内干预是大型绒毛膜血管瘤的治疗选择;当大型绒毛膜血管瘤伴粗大供血血管位于后壁胎盘时,双孔经皮技术似乎可提高胎儿镜激光光凝的效率;作者提出大型绒毛膜血管瘤的宫内干预应在胎儿水肿发生前启动。

研究设计与样本

  • 回顾性队列研究,单中心2011年1月至2022年12月共34例因大型胎盘绒毛膜血管瘤(直径≥4 cm)转诊患者,分为期待管理组25例(73.5%)与宫内干预组9例(26.5%);干预方式包括射频消融、间质激光消融及单孔或双孔胎儿镜激光光凝,治疗选择取决于肿瘤距脐带插入处距离及胎盘位置。

关键影像表现/征象

  • 干预组术前所有有资料病例的联合心输出量均升高,术前水肿见于33.3%(3/9)病例。
  • 1例在计划胎儿镜激光光凝前接受宫内输血后发生胎死宫内。
  • 其余8例中,4例行双孔胎儿镜激光光凝,2例行单孔胎儿镜激光光凝,1例行间质激光消融,1例行间质激光消融联合射频消融。

诊断标准与关键数值

  • 大型胎盘绒毛膜血管瘤定义为直径≥4 cm。
  • 宫内干预指征为胎儿出现任何濒临受损征象,包括联合心输出量升高、羊水过多加重或胎儿多普勒血流测值异常。
  • 双孔技术用于后壁胎盘且供血血管粗大(≥3 mm)的绒毛膜血管瘤,一孔用双极钳闭塞、另一孔对下游供血血管行激光光凝;单孔技术用于后壁胎盘且供血血管细小(<3 mm)者;前壁胎盘者行间质激光消融或射频消融。

临床应用与阅片要点

  • 对于大型胎盘绒毛膜血管瘤,可根据肿瘤与脐带插入处的距离及胎盘位置选择宫内干预方式。
  • 后壁胎盘伴粗大供血血管(≥3 mm)时可采用双孔经皮技术,一孔双极钳闭塞、另一孔激光光凝下游供血血管。
  • 后壁胎盘伴细小供血血管(<3 mm)时可采用单孔技术;前壁胎盘者可行间质激光消融或射频消融。
  • 羊水过多加重时可行羊水减量,根据大脑中动脉多普勒血流检查怀疑胎儿贫血时可行宫内输血。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: There is a paucity of literature providing evidence-based guidelines for the management of large placental chorioangioma (≥ 4 cm in diameter). The objectives of this study were to compare outcomes between patients managed expectantly and those undergoing in-utero intervention and to describe the different in-utero techniques used for cessation of blood flow to the tumor and the associated outcome.

METHODS: This was a retrospective cohort study of 34 patients referred for the management of large placental chorioangioma in a single center between January 2011 and December 2022, who were managed expectantly or underwent in-utero intervention. In-utero intervention was performed when the fetus developed any signs of impending compromise, including high combined cardiac output (CCO), worsening polyhydramnios or abnormal fetal Doppler velocimetry findings. Interventions included radiofrequency ablation (RFA), interstitial laser ablation (ILA) and single-port or two-port fetoscopic laser photocoagulation (FLP). Treatment selection was dependent on the proximity of the tumor to the umbilical cord insertion (UCI) and placental location. The two-port technique was performed in patients with a chorioangioma with large feeding vessels (≥ 3 mm) located in the posterior placenta, in which one port was used for occlusion using bipolar forceps and the other port was used for laser photocoagulation of the feeding vessels downstream. The single-port technique was used for chorioangioma with small feeding vessels (< 3 mm) located in the posterior placenta. ILA or RFA was performed in cases with an anterior placenta. Supportive treatments, including amnioreduction and intrauterine transfusion (IUT), were performed for worsening polyhydramnios and suspected fetal anemia based on middle cerebral artery Doppler flow studies, respectively. Comparative statistical analysis between cases undergoing expectant management vs in-utero intervention was performed. Descriptive details were provided for patients who underwent in-utero intervention.

RESULTS: Thirty-four cases of large chorioangioma were evaluated, of which 25 (73.5%) were managed expectantly and nine (26.5%) underwent intervention. The frequency of polyhydramnios was significantly higher in the intervention group compared with the expectant-management group (66.7% vs 8.0%, P < 0.001). The live-birth rate among expectantly managed cases with large chorioangioma was significantly higher compared with that in cases that underwent in-utero intervention (96.0% vs 62.5%, P = 0.01). In the intervention group, preoperative CCO was elevated in all cases with available information and preoperative hydrops was present in 33.3% (3/9) of cases. One patient experienced fetal demise following IUT prior to planned FLP. Among the remaining eight patients, four underwent two-port FLP, two underwent single-port FLP, one underwent ILA and one underwent both ILA and RFA. All three cases in which hydrops was present at the time of intervention resulted in fetal demise.

CONCLUSIONS: In-utero interventions aimed at cessation of blood flow in the feeding vessels are a therapeutic option for the management of cases with large chorioangioma. The two-port percutaneous technique appears to improve the efficiency of FLP when a large chorioangioma with large feeding vessels is located in the posterior placenta. We propose that in-utero interventions for large chorioangioma should be initiated prior to the development of fetal hydrops. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Agarwal N, Papanna R, Bergh EP, et al. Management of large placental chorioangioma: two-port laser approach for fetal intervention. Ultrasound Obstet Gynecol. 2023. PMID: 37448172. doi:10.1002/uog.26307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。